Our findings are of great potential therapeutic significance both in terms of routes whereby OXT can be administered during interventions in psychiatric disorders and in terms of the utility of VC pretreatment for minimizing entry of drugs administered intranasally into the peripheral circulation which might result in adverse effects. This evidence concerns the gene OXT and psychiatric disorder.